Timeline
MBP134
Experimental cross-species Ebola antibody cocktail; first authorised therapeutic intervention in the 2026 outbreak.
7 of 7 entries (7 events, 0 interactions)
Filters
#92 Jul
Formed one of four randomised treatment arms alongside remdesivir
Pandemics and Biosecurity: Ebola trial doses its first patient#817 Jun
Mentioned in: Africa CDC wins direct pandemic funding
Pandemics and Biosecurity#712 Jun
Entered first authorised clinical trial as two-antibody treatment arm for Bundibugyo Ebola
Pandemics and Biosecurity: First Ebola treatment trial goes live#51 Jun
Remained unauthorised to dose any patient as of 29 May
Pandemics and Biosecurity: Only Ebola treatment still cannot dose#61 Jun
$112m for vaccines, none for the wards
Pandemics and Biosecurity#420 May
Demonstrated 100% animal protection up to eight days post-infection and awaited regulatory clearance for human trial
Pandemics and Biosecurity: Ebola drug trial awaits DRC, Uganda nod#420 May